Skip to main content

Table 2 Effects of placebo and plant stanol yoghurt on lipid profile (mean ± SD) a

From: The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trial

 

Placebo yoghurt group

Plant stanol yoghurt group

pb

Baseline

Intervention

Change (%)

Baseline

Intervention

Change (%)

Total cholesterol (mg/dl)

233.4 ± 26.83

235.0 ± 23.75

1.2 ± 8.11

241.1 ± 25.81

232.0 ± 22.12

−3.4 ± 7.60

0.007*

LDL cholesterol (mg/dl)

154.5 ± 21.16

154.1 ± 18.58

0.5 ± 10.65

157.9 ± 26.40

147.7 ± 24.41

−5.8 ± 10.90

0.005*

HDL cholesterol (mg/dl)

51.2 ± 11.36

50.6 ± 11.62

−0.9 ± 10.76

50.1 ± 14.35

49.6 ± 15.79

−1.2 ± 8.87

0.524

Triglycerides (mg/dl)

138.5 ± 66.41

151.6 ± 66.45

19.8 ± 53.75

165.9 ± 99.42

174.0 ± 84.62

11.2 ± 27.05

0.606

VLDL cholesterol (mg/dl)

27.7 ± 13.27

30.3 ± 13.26

19.8 ± 53.60

33.1 ± 19.88

34.8 ± 16.92

11.3 ± 27.06

0.596

Non-HDL cholesterol (mg/dl)

182.2 ± 24.54

184.4 ± 20.86

2.0 ± 12.98

191.0 ± 28.24

182.5 ± 26.45

−4.2 ± 10.73

0.005*

Apolipoprotein A-I (mg/dl)

155.9 ± 20.50

154.3 ± 19.28

−0.8 ± 6.02

152.7 ± 26.12

154.4 ± 33.25

1.4 ± 13.17

0.602

Apolipoprotein B (mg/dl)

122.1 ± 19.92

121.1 ± 20.28

−0.4 ± 8.72

128.2 ± 20.09

121.0 ± 19.18

−5.0 ± 11.81

0.076

Lipoprotein-a (mg/dl)

27.8 ± 26.86

29.3 ± 27.78

4.1 ± 18.13

35.8 ± 31.18

32.6 ± 29.39

−2.8 ± 25.36

0.094

  1. a :Baseline is Week 0, Intervention is the average of Week 3 and Week 4. Value of Week 2 was used in the calculation of p value, but data was not given at table.
  2. b *p<0.05: Group by time interaction (Repeated measured variance of analysis – general linear model).